OmniAb OABI
NASDAQ OABI
$4.38 -0.37 (-7.87%)
As of: Sep 4, 2026 · 2:21 PM EDT

OmniAb (OABI) Assets Average (2021 - 2026)

OmniAb (OABI) posted quarterly Assets Average of $297.3 million for Q1 2026, down 5.88% year-over-year from $315.9 million in Q1 2025, and down 2.63% quarter-over-quarter from $305.3 million in Q4 2025.

Analysis

OmniAb (OABI) Assets Average (2021 - 2026) Analysis & Trends

OmniAb (OABI) has reported Assets Average for 6 consecutive years, with $297.3 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Assets Average fell 5.88% year-over-year to $297.3 million; the TTM figure through Mar 2026 stood at $297.3 million (down 5.88% YoY), while the FY2025 annual figure was $313.2 million, down 10.6% from the prior year.
  • Assets Average slipped to $297.3 million in Q1 2026 per OABI's latest filing, from $305.3 million in the prior quarter.
  • Across five years, Assets Average topped out at $417.1 million in Q1 2023 and bottomed at $236.8 million in Q2 2022.
  • Historically, Assets Average has averaged $328.0 million across 5 years, with a median of $328.6 million in 2024.
  • Annual changes were most pronounced in 2022 — Assets Average surged 99.64% — and 2024, when it declined 16.08%.
  • OmniAb's Assets Average stood at $329.4 million in 2022, then gained by 16.41% to $383.5 million in 2023, then dropped by 14.32% to $328.6 million in 2024, then retreated by 7.08% to $305.3 million in 2025, then dropped by 2.63% to $297.3 million in 2026.
  • Business Quant data shows OABI's Assets Average at $297.3 million in Q1 2026, $305.3 million in Q4 2025, and $302.7 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets Avg. (Qtr)
1 Vertex Pharmaceuticals 138.92 Bn 131.07 Bn 2.84 Bn 26.95 Bn
2 Regeneron Pharmaceuticals 85.55 Bn 77.56 Bn 3.93 Bn 41.30 Bn
3 Argenx Se 63.55 Bn 58.37 Bn 1.37 Bn -
4 Moderna 58.26 Bn 53.13 Bn 52.00 Mn 11.22 Bn
5 Revolution Medicines 44.08 Bn 44.08 Bn - 3.29 Bn
6 BeOne Medicines 39.98 Bn 34.89 Bn 1.53 Bn 8.86 Bn
7 Alnylam Pharmaceuticals 35.32 Bn 32.01 Bn 992.69 Mn 5.34 Bn
8 Royalty Pharma 28.42 Bn 27.59 Bn - 19.82 Bn
9 Insmed 27.41 Bn 26.25 Bn 358.27 Mn 2.09 Bn
10 OmniAb 564.12 Mn 512.13 Mn 12.81 Mn 291.95 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 291.95 Mn
Mar 31, 2026 297.28 Mn
Dec 31, 2025 305.30 Mn
Sep 30, 2025 302.68 Mn
Jun 30, 2025 300.93 Mn
Mar 31, 2025 315.87 Mn
Dec 31, 2024 328.56 Mn
Sep 30, 2024 334.41 Mn
Jun 30, 2024 344.91 Mn
Mar 31, 2024 363.89 Mn
Dec 31, 2023 383.47 Mn
Sep 30, 2023 398.47 Mn
Jun 30, 2023 409.14 Mn
Mar 31, 2023 417.13 Mn
Dec 31, 2022 329.41 Mn
Sep 30, 2022 237.20 Mn
Jun 30, 2022 236.85 Mn
Mar 31, 2022 270.68 Mn
Dec 31, 2021 270.73 Mn
Sep 30, 2021 118.81 Mn